(Q44420278)

2 December 2017

title

Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group (English)

1 reference

2 December 2017

1 reference

1 reference

Jones RB

1

1 reference

2 December 2017

Schwebke J

2

1 reference

2 December 2017

Thorpe EM Jr

3

1 reference

2 December 2017

Dalu ZA

4

1 reference

2 December 2017

Leone P

5

1 reference

2 December 2017

Johnson RB

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

American Journal of Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

104

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

28-32

1 reference

National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

In vitro activity of the new fluoroquinolone CP-99,219.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

Drugs of choice for the treatment of uncomplicated gonococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

Temporal trends in gonococcal antibiotic resistance in Baltimore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900277-5

10.1016/S0002-9343(97)00277-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference